Bosutinib Dimer Impurity
Synchemia is a leading supplier in pharmaceutical Bosutinib Impurities . Bosutinib is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer of the white blood cells), including treatment in adults who have been recently found to have this condition and in those who can no longer benefit from other medications for CML .
Bosutinib Dimer Impurity CAS NO: NA chemically represented as 4-((3-((3-Cyano-4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxyquinolin-7-yl)oxy)propyl)(2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile . Bosutinib Dimer Impurity is supplied with comprehensive characterization data, in full compliance with applicable regulatory guidelines. Synchemia is the leading supplier and exporter of Bosutinib Dimer Impurity . All Synchemia products are strictly intended for analytical testing purposes only and not for human use.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-B30101 |
| CAS No | 380843-75-4 |
| Mol.F. | C26H29Cl2N5O3 |
| Mol.Wt. | 530.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30102 |
| CAS No | 2468737-94-0 |
| Mol.F. | C24H25Cl2N5O3 |
| Mol.Wt. | 502.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30103 |
| CAS No | 2468737-92-8 |
| Mol.F. | C25H27Cl2N5O3 |
| Mol.Wt. | 516.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30104 |
| CAS No | 380843-81-2 |
| Mol.F. | C25H27Cl2N5O3 |
| Mol.Wt. | 516.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30106 |
| CAS No | 2095306-25-3 |
| Mol.F. | C21H19Cl2N3O3 |
| Mol.Wt. | 432.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30107 |
| CAS No | 142072-71-7 |
| Mol.F. | C10H11NO4 |
| Mol.Wt. | 209.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30108 |
| CAS No | 636-93-1 |
| Mol.F. | C7H7NO4 |
| Mol.Wt. | 169.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30109 |
| CAS No | 98446-49-2 |
| Mol.F. | C7H7Cl2NO |
| Mol.Wt. | 192g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30110 |
| CAS No | NA |
| Mol.F. | C26H30ClN5O4 |
| Mol.Wt. | 512g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30111 |
| CAS No | 2095306-26-4 |
| Mol.F. | C46H44Cl4N8O6 |
| Mol.Wt. | 946.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30112 |
| CAS No | 2095306-27-5 |
| Mol.F. | C39H30Cl4N6O6 |
| Mol.Wt. | 820.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30113 |
| CAS No | 1391063-17-4 |
| Mol.F. | C26H29Cl2N5O3 |
| Mol.Wt. | 530.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30114 |
| CAS No | 380843-75-4 |
| Mol.F. | C26H29Cl2N5O3 : H2O |
| Mol.Wt. | 530.5 : 18.0g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30115 |
| CAS No | NA |
| Mol.F. | C27H31Cl3N5O3 |
| Mol.Wt. | 579.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30116 |
| CAS No | NA |
| Mol.F. | C26H29Cl2N5O5 |
| Mol.Wt. | 562.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30117 |
| CAS No | 2468737-96-2 |
| Mol.F. | C26H29Cl2N5O4 |
| Mol.Wt. | 546.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |